EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 42 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,679,000 | -34.4% | 475,000 | -7.1% | 0.71% | -15.2% |
| Q4 2017 | $7,135,000 | +24.7% | 511,469 | -1.7% | 0.84% | +2.4% |
| Q3 2017 | $5,723,000 | +88.0% | 520,269 | +35.0% | 0.82% | +58.0% |
| Q2 2017 | $3,044,000 | -31.0% | 385,301 | 0.0% | 0.52% | -40.1% |
| Q1 2017 | $4,412,000 | -1.7% | 385,301 | 0.0% | 0.86% | -24.0% |
| Q4 2016 | $4,489,000 | -10.3% | 385,301 | +3.1% | 1.14% | +39.6% |
| Q3 2016 | $5,002,000 | +67.5% | 373,568 | +147.9% | 0.81% | +4.9% |
| Q2 2016 | $2,987,000 | +20.7% | 150,716 | +2.2% | 0.78% | +44.8% |
| Q1 2016 | $2,474,000 | – | 147,514 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |